Raltegravir, tenofovir, and emtricitabine in an HIV-Infected patient with HCV chronic hepatitis, NNRTI intolerance and protease inhibitors-induced severe liver toxicity

BACKGROUND: in HIV-infected patients with HCV-related chronic hepatitis, liver impairment and drug toxicity may substantially reduce the number of possible therapeutic options. CASE DESCRIPTION: we here describe the case of an HCV-HIV coinfected woman who had repeated severe episodes of drug-related...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortu, F, Weimer, LE, Floridia, M, Manconi, PE
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352050/
https://www.ncbi.nlm.nih.gov/pubmed/20452889
http://dx.doi.org/10.1186/2047-783X-15-2-81

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3352050/
https://www.ncbi.nlm.nih.gov/pubmed/20452889
http://dx.doi.org/10.1186/2047-783X-15-2-81

Ejemplares similares